Apyx Medical Corp Deferred Tax Assets, Net of Valuation Allowance
Apyx Medical Corp (APYX) had Deferred Tax Assets, Net of Valuation Allowance of $1.31 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.31M.
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.36M.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.59M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $457.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $1.31M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $1.36M 10-K · filed 2026-03-10 | |
| 2023-12-31 | $1.59M 10-K · filed 2025-03-13 | |
| 2022-12-31 | $457.00K 10-K · filed 2024-03-21 | |
| 2021-12-31 | $430.00K 10-K · filed 2023-03-16 | |
| 2020-12-31 | $399.00K 10-K · filed 2022-03-17 | |
| 2019-12-31 | $444.00K 10-K · filed 2021-03-31 | |
| 2018-12-31 | $150.00K 10-K · filed 2020-03-31 | |
| 2017-12-31 | $187.00K 10-K · filed 2020-03-31 | |
| 2016-12-31 | $300.00K 10-K · filed 2019-03-14 | |
| 2015-12-31 | $196.00K 10-K · filed 2017-03-10 | -$564.00K 10-K · filed 2016-03-18 |
| 2014-12-31 | -$564.00K 10-K · filed 2016-03-18 | |
| 2013-12-31 | $3.41M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |